checkAd

     165  0 Kommentare Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024 - Seite 2

    DANYELZA and Y-mAbs are registered trademarks of Y-mAbs Therapeutics, Inc.

    Investor Contact:

    Lesen Sie auch

    Courtney Dugan
    VP, Head of Investor Relations
    cdu@ymabs.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024 - Seite 2 NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) - Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter and full year ended December 31, 2023, on Thursday, February …